Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Endocrinology

Building Your Child's Care Plan: Standard Treatments

At a Glance

The gold standard of care for Prader-Willi syndrome involves a multidisciplinary team to manage growth hormone therapy, early physical and behavioral interventions, and strict environmental controls for hyperphagia. Close monitoring for respiratory infections and sleep apnea is required.

Managing Prader-Willi Syndrome (PWS) requires a proactive, “whole-person” approach. Because PWS affects multiple systems—including growth, metabolism, and behavior—the gold standard of care is a multidisciplinary team [1]. This team typically includes an endocrinologist, a specialized nutritionist, a sleep specialist or pulmonologist, a behavioral therapist, and various physical therapists [2].

Growth Hormone (GH) Therapy

Growth Hormone therapy is a cornerstone of modern PWS management. Administered via a daily subcutaneous injection (a small shot under the skin), it is not just about height; it fundamentally changes how the body is built [3].

Benefits of GH Therapy

  • Body Composition: GH significantly improves muscle mass (lean body mass) and helps reduce body fat [4].
  • Growth and Stature: It helps children reach a height more in line with their peers [3].
  • Bone Health: GH therapy has a positive effect on bone mineral density, making bones stronger as children grow [5].

Risks and Safety Monitoring

While GH is widely used and highly effective, it requires careful medical oversight:

  • Sleep-Disordered Breathing: In some children, GH can worsen obstructive sleep apnea (where breathing stops and starts during sleep) [3]. Doctors recommend a polysomnography (sleep study) before starting treatment and regular follow-ups [6].
  • Respiratory Infections (Critical Warning): Pediatric patients with PWS on GH therapy have an increased risk of sudden death associated with severe obesity or acute respiratory infections [3]. Parents must be extremely vigilant and promptly report any severe colds, chest congestion, or respiratory infections to their doctor.
  • Scoliosis Monitoring: Children with PWS have a higher risk of developing scoliosis (curvature of the spine). While GH does not seem to cause scoliosis, your child will need regular spine checks while on the medication [7].

Managing Hyperphagia

Hyperphagia—the insatiable drive to eat—is a physiological symptom of PWS that cannot be “cured” with willpower or traditional dieting. Instead, it is managed through environmental control and structure [8].

  • Food Security: Creating a “food-secure” environment is essential. This often involves locking cabinets or pantries and providing a highly predictable meal schedule to reduce the child’s anxiety around food [9].
  • Caloric Management: Because individuals with PWS have a lower metabolism and less muscle mass, they require fewer calories than their peers to maintain a healthy weight [10]. A nutritionist will help create a specialized, nutrient-dense plan.

Early and Ongoing Therapy

From infancy, Physical Therapy (PT) and Occupational Therapy (OT) are critical to address neonatal hypotonia (low muscle tone), promoting the strength needed to reach milestones like crawling and walking [11]. Furthermore, early Behavioral Therapy is crucial to help parents establish rigid routines and prepare strategies to manage the unique behavioral challenges (temper tantrums, stubbornness, skin-picking) that will emerge as the child grows [12].

Back to Home Page.

Common questions in this guide

Why is growth hormone therapy used for Prader-Willi syndrome?
Growth hormone therapy fundamentally improves body composition by increasing muscle mass and reducing body fat. It also helps children reach a more typical height and strengthens bone mineral density as they grow.
What are the risks of growth hormone therapy for children with PWS?
Growth hormone therapy can worsen obstructive sleep apnea, so doctors require a sleep study before starting treatment. There is also an increased risk of severe respiratory infections, which parents must monitor closely and report immediately to their doctor.
How can parents manage hyperphagia in a child with PWS?
Hyperphagia cannot be managed with willpower or traditional dieting. Instead, parents must use environmental controls, such as locking pantries and providing a highly predictable meal schedule to reduce anxiety around food.
What types of early therapies are needed for infants with PWS?
Physical and occupational therapy are critical from infancy to address low muscle tone and help the child reach milestones like crawling and walking. Early behavioral therapy is also essential to establish rigid routines and prepare for future behavioral challenges.
Do children on growth hormone therapy need to be monitored for scoliosis?
Yes, children with Prader-Willi syndrome have a higher risk of developing a curvature of the spine known as scoliosis. While growth hormone does not cause scoliosis, regular spine checks are necessary while the child is on this medication.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What are the specific parameters you will monitor in the upcoming sleep study to ensure it is safe to continue or adjust Growth Hormone therapy?
  2. 2.Based on my child's current age, what is the target caloric intake recommended by the nutritionist?
  3. 3.How often should we screen for scoliosis while my child is on Growth Hormone therapy?
  4. 4.What is the protocol if my child develops a severe cold or respiratory infection while on GH therapy?
  5. 5.Can you help us coordinate a behavioral therapy plan to proactively address tantrums and rigidity?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (12)
  1. 1

    A review of Prader-Willi syndrome.

    Metzler S, Brown GR

    JAAPA : official journal of the American Academy of Physician Assistants 2025; (38(2)):e1-e6 doi:10.1097/01.JAA.0000000000000079.

    PMID: 39846602
  2. 2

    Recommendations for the diagnosis and management of childhood Prader-Willi syndrome in China.

    Yang-Li D, Fei-Hong L, Hui-Wen Z, et al.

    Orphanet journal of rare diseases 2022; (17(1)):221 doi:10.1186/s13023-022-02302-z.

    PMID: 35698200
  3. 3

    Sleep-disordered breathing in Australian children with Prader-Willi syndrome following initiation of growth hormone therapy.

    Caudri D, Nixon GM, Nielsen A, et al.

    Journal of paediatrics and child health 2022; (58(2)):248-255 doi:10.1111/jpc.15691.

    PMID: 34397126
  4. 4

    Three years of growth hormone treatment in young adults with Prader-Willi Syndrome previously treated with growth hormone in childhood: Effects on glucose homeostasis and metabolic syndrome.

    Damen L, Grootjen LN, Donze SH, et al.

    Clinical endocrinology 2020; (93(4)):439-448 doi:10.1111/cen.14274.

    PMID: 32609902
  5. 5

    Bone mineral density in young adults with Prader-Willi syndrome: A randomized, placebo-controlled, crossover GH trial.

    Donze SH, Kuppens RJ, Bakker NE, et al.

    Clinical endocrinology 2018; (88(6)):806-812 doi:10.1111/cen.13567.

    PMID: 29418016
  6. 6

    Sleep-disordered breathing in school-aged children with Prader-Willi syndrome.

    Schaefer J, Davey MJ, Nixon GM

    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2022; (18(4)):1055-1061 doi:10.5664/jcsm.9788.

    PMID: 34870583
  7. 7

    Growth hormone treatment in children with Prader-Willi syndrome: safety and effectiveness data from the PATRO Children study.

    Lämmer C, Backeljauw P, Tauber M, et al.

    Therapeutic advances in endocrinology and metabolism 2024; (15()):20420188241264343 doi:10.1177/20420188241264343.

    PMID: 39371577
  8. 8

    Prader-Willi Syndrome: Clinical Genetics and Diagnostic Aspects with Treatment Approaches.

    Butler MG, Manzardo AM, Forster JL

    Current pediatric reviews 2016; (12(2)):136-66 doi:10.2174/1573396312666151123115250.

    PMID: 26592417
  9. 9

    Analysis of Hyperphagia Questionnaire for Clinical Trials (HQ-CT) scores in typically developing individuals and those with Prader-Willi syndrome.

    Matesevac L, Vrana-Diaz CJ, Bohonowych JE, et al.

    Scientific reports 2023; (13(1)):20573 doi:10.1038/s41598-023-48024-5.

    PMID: 37996659
  10. 10

    Early Detection and Management of Prader-Willi Syndrome in Egyptian Patients.

    El-Bassyouni HT, Hassan N, Mahfouz I, et al.

    Journal of pediatric genetics 2019; (8(4)):179-186 doi:10.1055/s-0039-1695042.

    PMID: 31687254
  11. 11

    Early psychomotor development and growth hormone therapy in children with Prader-Willi syndrome: a review.

    Jin YY, Luo FH

    European journal of pediatrics 2024; (183(3)):1021-1036 doi:10.1007/s00431-023-05327-z.

    PMID: 37987848
  12. 12

    Psychiatric care for people with Prader-Willi syndrome-characteristics, needs and barriers.

    Wieting J, Herrmann T, Deest-Gaubatz S, et al.

    Journal of applied research in intellectual disabilities : JARID 2024; (37(4)):e13266 doi:10.1111/jar.13266.

    PMID: 38863266

This page provides educational information on standard treatments for Prader-Willi syndrome. It does not replace professional medical advice; always consult your pediatric endocrinologist and care team regarding your child's specific plan.

Get notified when new evidence is published on Prader-Willi syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.